Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

as compared to a net loss of $31.0 million or $0.33 per share in the third quarter of 2009.

Conference Call to Discuss Third Quarter 2010 Financial ResultsA conference call to review the financial results will be held today, Thursday, November 4, 2010 at 2 PM Pacific Time.  

Details are below:

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, November 19, 2010. To access the conference call, follow these instructions:Dial: (800) 798-2864 (U.S.); (617) 614-6206 (international)Passcode: 87996589 (Nektar is the host)An audio replay will also be available shortly following the call through Friday, November 19, 2010 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 55049373.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 development program to treat opioid-induced constipation and its NKTR-119 development program for the treatment of pain without constipation side effects. The company has additional pain compounds in prec
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...  Frequentz Inc., a global leader and champion of ... help the pharmaceutical industry understand the current and future ... (DSCSA). The white paper, "From Lot-based to Serialization-based Traceability", ... Standard(s) and Implementation Plan rollout, as well as ... that need to occur between now and the 2017 ...
(Date:3/31/2015)... 2015 Medela has announced the addition ... ® Motion™-Endure personal pumps to its Negative Pressure ... These new devices, along with the Invia ® ... provide innovative, high-quality NPWT solutions, designed to provide ... "We are happy to be able ...
(Date:3/31/2015)... PGI has announced an expansion of its ... at its San Luis Potosi, ... expansion is centered on solving the challenge of complicated ... personal care product manufacturers. The planned ... and packaging, will allow customers to take advantage of ...
Breaking Medicine Technology:Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2PGI Expands Manufacturing Capabilities At Mexico Plant 2
... Sept. 29, 2011 The U.S. Food and Drug ... the International Internet Week of Action (IIWA), a cooperative ... and illegal medical products. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... between Sept. 20 and Sept. 27 is called OPERATION ...
... Sept. 29, 2011 CIVCO ... installed at the Instituto Radioterapia del Este in Puerto ... the Protura system elevates the level of radiation therapy ... need for many patients to travel for treatment. ...
Cached Medicine Technology:FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 2FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 3FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 4CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 2CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 3
(Date:3/31/2015)... (PRWEB) March 31, 2015 Due ... started to hire more caregivers, staffing personnel, and ... and care managers within the Greater Los Angeles ... training institution, 1Heart Caregiver University has firmed up ... its mission to provide quality in-home care through ...
(Date:3/31/2015)... Over the last several years, many improvements ... yielded better results and more efficient procedures. Similarly, the ... a good hair transplant surgeon, has resulted in astonishingly ... restoration have improved the efficiency of hair restoration procedures, ... precision and flexibility to the field of hair restoration. ...
(Date:3/31/2015)... 2015 In honor of National ... advice for buying from a NMEDA QAP certified ... is a nonprofit organization that provides consumer guidance ... and installation of mobility equipment. The organization’s Quality ... that consistently adhere to the highest quality safety ...
(Date:3/31/2015)... FL (PRWEB) March 31, 2015 Medical ... America, has met all criteria for Laboratory Accreditation by ... given only to laboratories that apply rigid standards of ... performance of proficiency testing, and pass a rigorous on-site ... COLA accreditation as a result of a long-term commitment ...
(Date:3/31/2015)... The Walk a Mile Project, as part of ... kicked off their 3rd research sequence. The new sequence ... Equivalence was and is a massive component of GMO ... Change The World Films. “We started our research by ... entered our food supply, just to get a bird's eye ...
Breaking Medicine News(10 mins):Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2
... Lynne Eldridge, M.D., author,of Avoiding Cancer One Day At ... common forms of cancer during a series of FREE seminars ... in downtown San Jose on,Sunday October 28th between 10am and ... the tech museum you can also visit the,amazing Body Worlds ...
... the University at Buffalo,s Research Institute on Addictions (RIA) ... technique often used in behavioral medicine for stress reduction ... of alcohol use disorders. , ... reduction or MBSR in alcoholism treatment, we hope to ...
... cut with more testing and early detection, , , FRIDAY, ... women think that if there,s no family history of ... new survey found. , In fact, most people who ... to the American College of Obstetricians and Gynecologists (ACOG), ...
... Oct. 26 Peak International Limited,(Nasdaq: PEAK ) ... fiscal year 2008 ended September 30, 2007 will be ... A conference call to,discuss the results of the quarter ... 2007 at 10:00 AM ET. To access the ...
... third quarter financial results -, LAVAL, QC, Oct. ... announced that it will host a conference call on,Friday, ... its third quarter,2007 financial results. Labopharm will report its ... 7:00 a.m. the same day. To access the ...
... by Truth Wins Out:, What: The National Association ... annual meeting at the Dallas/Ft. Worth,Airport Marriott on October ... heterosexuals with a homosexual problem." A coalition of local ... 11AM, followed,by a demonstration against this controversial fringe group ...
Cached Medicine News:Health News:Author Reveals How to Cancer Proof Your Life on October 28th 2Health News:Dealing with stress as a treatment for alcohol abuse 2Health News:Survey Finds Many Women Misinformed About Cancer 2Health News:Survey Finds Many Women Misinformed About Cancer 3Health News:Peak International Sets Time for Discussion of Second Quarter Fiscal 2008 Financial Results 2Health News:Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET) 2Health News:Major Protest On Saturday Against Fringe Therapists Who Claim to 'Cure' Gays 2
... Delta Specialty / Drug Clinical System ... can consolidate Drugs of Abuse, TDM's ... thyroid, HbA1c and lipids in one ... a level of automation and flexibility ...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w...
Medicine Products: